Central Bank & Trust’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-40
| Closed | -$18.7K | – | 349 |
|
|
2024
Q2 | $18.7K | Hold |
40
| – | – | ﹤0.01% | 292 |
|
|
2024
Q1 | $16.7K | Sell |
40
-58
| -59% | -$24.2K | ﹤0.01% | 276 |
|
|
2023
Q4 | $39.9K | Sell |
98
-16
| -14% | -$6.51K | 0.01% | 253 |
|
|
2023
Q3 | $39.6K | Hold |
114
| – | – | 0.01% | 237 |
|
|
2023
Q2 | $40.1K | Sell |
114
-27
| -19% | -$9.5K | 0.01% | 233 |
|
|
2023
Q1 | $44.4K | Buy |
141
+109
| +341% | +$34.3K | 0.01% | 231 |
|
|
2022
Q4 | $9.24K | Hold |
32
| – | – | ﹤0.01% | 291 |
|
|
2022
Q3 | $9K | Sell |
32
-133
| -81% | -$37.4K | ﹤0.01% | 282 |
|
|
2022
Q2 | $46K | Sell |
165
-80
| -33% | -$22.3K | 0.01% | 228 |
|
|
2022
Q1 | $64K | Buy |
245
+165
| +206% | +$43.1K | 0.01% | 218 |
|
|
2021
Q4 | $18K | Sell |
80
-1,244
| -94% | -$280K | ﹤0.01% | 267 |
|
|
2021
Q3 | $240K | Buy |
1,324
+25
| +2% | +$4.53K | 0.04% | 152 |
|
|
2021
Q2 | $262K | Buy |
1,299
+56
| +5% | +$11.3K | 0.04% | 149 |
|
|
2021
Q1 | $267K | Buy |
1,243
+70
| +6% | +$15K | 0.05% | 144 |
|
|
2020
Q4 | $277K | Buy |
1,173
+702
| +149% | +$166K | 0.05% | 135 |
|
|
2020
Q3 | $128K | Buy |
471
+420
| +824% | +$114K | 0.02% | 162 |
|
|
2020
Q2 | $15K | Hold |
51
| – | – | ﹤0.01% | 214 |
|
|
2020
Q1 | $12K | Buy |
+51
| New | +$12K | ﹤0.01% | 220 |
|
|
2019
Q2 | – | Sell |
-24
| Closed | -$4K | – | 280 |
|
|
2019
Q1 | $4K | Hold |
24
| – | – | ﹤0.01% | 257 |
|
|
2018
Q4 | $4K | Hold |
24
| – | – | ﹤0.01% | 255 |
|
|
2018
Q3 | $5K | Buy |
+24
| New | +$5K | ﹤0.01% | 252 |
|
|
2016
Q2 | – | Sell |
-119
| Closed | -$9K | – | 345 |
|
|
2016
Q1 | $9K | Hold |
119
| – | – | ﹤0.01% | 278 |
|
|
2015
Q4 | $15K | Buy |
119
+85
| +250% | +$10.7K | ﹤0.01% | 261 |
|
|
2015
Q3 | $4K | Hold |
34
| – | – | ﹤0.01% | 351 |
|
|
2015
Q2 | $4K | Buy |
34
+7
| +26% | +$824 | ﹤0.01% | 338 |
|
|
2015
Q1 | $3K | Buy |
+27
| New | +$3K | ﹤0.01% | 313 |
|